Selective Janus kinase inhibitors: Promising drugs for rheumatoid arthritis

被引：1
作者：
Zanwar, Abhishek [1 ]
Aggarwal, Amita [1 ]
机构：
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Clin Immunol & Rheumatol, Lucknow, Uttar Pradesh, India
来源：
NATIONAL MEDICAL JOURNAL OF INDIA | 2019年 / 32卷 / 02期
关键词：
TOFACITINIB; ADALIMUMAB; PLACEBO; SAFETY;
D O I：
10.4103/0970-258X.275350
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：96 / +
页数：2
相关论文
共 50 条
  • [31] Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition
    Dowty, Martin E.
    Lin, Tsung H.
    Jesson, Michael I.
    Hegen, Martin
    Martin, David A.
    Katkade, Vaibhav
    Menon, Sujatha
    Telliez, Jean-Baptiste
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (06):
  • [32] Tofacitinib: A novel oral Janus kinase inhibitor for rheumatoid arthritis
    O'Dell, Kate M.
    Rummel, Ashley E.
    FORMULARY, 2012, 47 (10) : 350 - +
  • [33] Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis
    Wei, Xin
    Wu, Jianbo
    Zhao, Gang
    Galdamez, Josselyn
    Lele, Subodh M.
    Wang, Xiaoyan
    Liu, Yanzhi
    Soni, Dhruvkumar M.
    Purdue, P. Edward
    Mikuls, Ted R.
    Goldring, Steven R.
    Wang, Dong
    MOLECULAR PHARMACEUTICS, 2018, 15 (08) : 3456 - 3467
  • [34] Janus Kinase Inhibitors in Rheumatoid Arthritis: An Update on the Efficacy and Safety of Tofacitinib, Baricitinib and Upadacitinib
    Harrington, Robert
    Harkins, Patricia
    Conway, Richard
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [35] Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?
    Martinez-Molina, Cristina
    Feliu, Anna
    Park, Hye S.
    Juanes, Ana
    Diaz-Torne, Cesar
    Vidal, Silvia
    Corominas, Hector
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [36] Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
    Kotyla, Przemyslaw J.
    Islam, Md Asiful
    Engelmann, Malgorzata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 17
  • [37] Pharmacokinetic review of janus kinase inhibitors and its clinical implications for the management of rheumatoid arthritis
    Chandrashekara, S.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (08) : 741 - 748
  • [38] Drug efficacy and safety of biologics and Janus kinase inhibitors in elderly patients with rheumatoid arthritis
    Ebina, Kosuke
    MODERN RHEUMATOLOGY, 2022, 32 (02) : 256 - 262
  • [39] Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis
    Bower, Hannah
    Frisell, Thomas
    di Giuseppe, Daniela
    Delcoigne, Benedicte
    Askling, Johan
    RMD OPEN, 2023, 9 (04):
  • [40] Selective JAK inhibitors in development for rheumatoid arthritis
    Norman, Peter
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (08) : 1067 - 1077
12345